Derek Wiswell

1.4k total citations
14 papers, 934 citations indexed

About

Derek Wiswell is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Derek Wiswell has authored 14 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Derek Wiswell's work include Cancer-related Molecular Pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and DNA Repair Mechanisms (4 papers). Derek Wiswell is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and DNA Repair Mechanisms (4 papers). Derek Wiswell collaborates with scholars based in United States, China and Italy. Derek Wiswell's co-authors include Wolfgang Seghezzi, David Parry, Timothy J. Guzi, Nicole R. Davis, Kamil Paruch, Michael P. Dwyer, Thierry Fischmann, Fergus Shanahan, Emma Lees and Ronald J. Doll and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Developmental Biology.

In The Last Decade

Derek Wiswell

14 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek Wiswell United States	11	522	459	202	151	132	14	934
Arturo Galvani Italy	21	689 1.3×	418 0.9×	355 1.8×	142 0.9×	161 1.2×	55	1.2k
Timothy J. Guzi United States	16	792 1.5×	538 1.2×	258 1.3×	261 1.7×	160 1.2×	31	1.4k
Tammie C. Yeh United States	11	614 1.2×	503 1.1×	234 1.2×	81 0.5×	86 0.7×	21	1.0k
Martina S.J. McDermott United States	16	488 0.9×	438 1.0×	225 1.1×	104 0.7×	73 0.6×	33	969
Kate F. Byth United States	15	520 1.0×	400 0.9×	98 0.5×	228 1.5×	281 2.1×	20	1.0k
Glenn Spehar United States	7	499 1.0×	806 1.8×	234 1.2×	131 0.9×	132 1.0×	8	1.2k
Maureen R. Bleam United States	6	862 1.7×	548 1.2×	125 0.6×	105 0.7×	189 1.4×	13	1.1k
Babita Saigal United States	15	723 1.4×	460 1.0×	288 1.4×	82 0.5×	87 0.7×	26	1.2k
Linda Kessler United States	14	746 1.4×	352 0.8×	106 0.5×	137 0.9×	59 0.4×	38	1.1k
Michael Zinda United States	22	935 1.8×	469 1.0×	192 1.0×	128 0.8×	123 0.9×	37	1.4k

Countries citing papers authored by Derek Wiswell

Since Specialization

Citations

This map shows the geographic impact of Derek Wiswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Wiswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Wiswell more than expected).

Fields of papers citing papers by Derek Wiswell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Wiswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Wiswell. The network helps show where Derek Wiswell may publish in the future.

Co-authorship network of co-authors of Derek Wiswell

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Wiswell. A scholar is included among the top collaborators of Derek Wiswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Wiswell. Derek Wiswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zhang, Shuli, et al.. (2021). Development of a novel capillary electrophoresis-based approach for detection of anti-drug antibody responses. Journal of Immunological Methods. 494. 113047–113047. 4 indexed citations

Wiswell, Derek, Edward P. Bowman, Douglas E. Linn, et al.. (2020). A capillary electrophoresis based approach for the identification of anti-drug antibodies against camelid VHH biologics (Nanobodies®). Journal of Pharmacological and Toxicological Methods. 103. 106872–106872. 8 indexed citations

Demma, Mark J., Claudio Mapelli, Smaranda Bodea, et al.. (2019). Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene. Molecular and Cellular Biology. 39(22). 77 indexed citations

Yang, Xiaoyu, Fengqiang Wang, Ying Zhang, et al.. (2015). Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo. Journal of Pharmaceutical Sciences. 104(12). 4002–4014. 26 indexed citations

Mauze, Smita, Danling Gu, Derek Wiswell, et al.. (2015). The Role of Anti-Drug Antibodies in the Pharmacokinetics, Disposition, Target Engagement, and Efficacy of a GITR Agonist Monoclonal Antibody in Mice. Journal of Pharmacology and Experimental Therapeutics. 356(3). 574–586. 12 indexed citations

Antonenko, S. V., Roanna Ueda, Smita Mauze, et al.. (2015). Abstract 4521: Evaluation of the relationship between serum exposure, receptor (GITR) availability and tumor suppression following administration of the anti-GITR antibody DX400 in mouse syngeneic tumor models. Cancer Research. 75(15_Supplement). 4521–4521. 1 indexed citations

Huang, Xiaohua, Cliff C. Cheng, Thierry Fischmann, et al.. (2013). Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2590–2594. 26 indexed citations

Guzi, Timothy J., Kamil Paruch, Michael P. Dwyer, et al.. (2011). Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening. Molecular Cancer Therapeutics. 10(4). 591–602. 135 indexed citations

Parry, David, Timothy J. Guzi, Fergus Shanahan, et al.. (2010). Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor. Molecular Cancer Therapeutics. 9(8). 2344–2353. 434 indexed citations

10.

Dwyer, Michael P., Kamil Paruch, Marc Labroli, et al.. (2010). Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 1. Bioorganic & Medicinal Chemistry Letters. 21(1). 467–470. 55 indexed citations

11.

Labroli, Marc, Kamil Paruch, Michael P. Dwyer, et al.. (2010). Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 2. Bioorganic & Medicinal Chemistry Letters. 21(1). 471–474. 62 indexed citations

12.

Zhao, Lianyun, Yingxin Zhang, Chaoyang Dai, et al.. (2010). Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(24). 7216–7221. 34 indexed citations

13.

Dwyer, Michael P., Kamil Paruch, Carmen Álvarez, et al.. (2007). Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6216–6219. 29 indexed citations

14.

Hikita, Sherry T., et al.. (2004). Integrin α4β1 function is required for cell survival in developing retina. Developmental Biology. 276(2). 416–430. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact